The SAMR (State Administration for Market Regulation) Key Laboratory (Foods for Special Medical Purposes for Diabetes) aims to build effective innovation, translation and regulatory frameworks for future food technologies across the entire industry chain, addressing the dietary challenges faced by over 100 million diabetes patients in China. The laboratory develops a comprehensive series of medical nutrition foods for patients with diabetes and metabolic diseases, helping to reduce the incidence of diabetes and its complications, improve quality of life, and advance application research and innovation platforms for future foods for the Chinese population.